SAS Output

16-OCT-2019 6:10

LEUK ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1318-ALL, Age 65+, Ph±, Blinatumomab 1 Y 1 Induction: Ph- 44 31 0 0 0 0 0 06/30/2015 132 52
        2 Induction: Ph+/Ph-like   17 1 1 1 1 1      
            48 1 1 1 1 1      
 
    2 Y 3 Post-remission: Ph- 44 20 0 0 0 0 0 06/30/2015    
        4 Post-remission: Ph+/Ph-like   12 0 0 0 0 0      
            32 0 0 0 0 0      
 
    3 Y 5 Maintenance: Ph- 44 14 0 0 0 0 0 06/30/2015    
        6 Maintenance: Ph+/Ph-like   10 0 0 0 0 0      
            24 0 0 0 0 0      
 
  S1612-AML/MDS, Age 60+, Aza/Novel Therapeutics 1 T 0 FLT3 Testing 1670 113 4 0 0 0 0 02/02/2018 199 81
            113 4 0 0 0 0      
 
    2 T 1 Azacitidine 1670 26 0 0 0 0 0 02/02/2018    
        2 Azacitidine + Nivolumab   26 2 0 0 0 0      
        3 Azacitidine + Midostaurin   26 1 0 0 0 0      
            78 3 0 0 0 0      
 
  S1712-CML, Chronic Phase, TKI +/- Ruxolitinib 1 Y 1 Single Agent TKI 84 8 8 6 4 1 0 10/24/2018 163 62
        2 TKI + Ruxolitinib   5 5 2 2 0 0      
            13 13 8 6 1 0      
 
Yes A041701-AML, Age 60+, Conv Chemo +/- Uproleselan 0 E Total Registrations   10 10 10 5 2 0 06/10/2019 33 12
            10 10 10 5 2 0      
 
    1 E Total Registrations   6 6 6 3 1 0 06/10/2019    
            6 6 6 3 1 0      
 
  A041702-CLL, Stg I-IV, IO with IM versus IVO 0 E Total Registrations   17 17 14 9 2 0 03/04/2019 124 46
            17 17 14 9 2 0      
 
    1 E Total Registrations   13 13 11 8 3 0 03/04/2019    
            13 13 11 8 3 0      
 
  E1910-BCR-ABL-neg, B ALL, Blinatumomab 1 E Total Registrations   119 19 8 4 1 0 06/06/2014   81
            119 19 8 4 1 0      
 
  EA9161-CLL, untreated, IOV vs IO in younger pts 0 E Total Registrations   6 6 6 6 6 1 02/12/2019 261 111
            6 6 6 6 6 1      
 
    1 E Total Registrations   55 55 45 25 9 1 02/12/2019    
            55 55 45 25 9 1      
 
No A041501-B-Cell ALL, Frontline Tx +/- Intuzumab Ozo 0 E Total Registrations   9 9 5 2 0 0 11/09/2018 170 59
            9 9 5 2 0 0      
 
    1 E Total Registrations   6 6 4 2 0 0 11/09/2018    
            6 6 4 2 0 0      
 
    2 E Total Registrations   4 4 3 3 0 0 11/09/2018    
            4 4 3 3 0 0      
 
  E1910-BCR-ABL-neg, B ALL, Blinatumomab 0 E Total Registrations   166 28 14 7 1 0 06/06/2014   81
            166 28 14 7 1 0      
 
    2 E Total Registrations   77 16 8 4 1 0 06/06/2014    
            77 16 8 4 1 0      
 
    3 E Total Registrations   64 18 6 3 1 0 06/06/2014    
            64 18 6 3 1 0      
 
    4 E Total Registrations   28 7 6 4 1 0 06/06/2014    
            28 7 6 4 1 0